PTPRC and Alzheimer disease: The AD-MSCs revealed the fibroblast-like morphologyand were able to differentiate into osteocytes andadipocytes are indicated in Figure 2A, B, C, respectively.As indicated in Figure 2D, AD-MSCs expressed CD45,CD34, CD90, CD105, CD73 and CD29 cell surfacemarkers at percentages of 1.54, 1.12, 44.68, 61.55, 46.82and 95.7%, respectively.